診断用エキソソームバイオマーカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測

• 英文タイトル：Global Diagnostic Exosome Biomarker Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-15756 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、診断用エキソソームバイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。診断用エキソソームバイオマーカーの種類別市場規模（膜結合タンパク質、可溶性タンパク質、ノンコーディングRNA、その他）、用途別市場規模（病院、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：101Bio、Bio-Techne、Cell Guidance Systems、AMS Biotechnology、ExoCyte Therapeutics、BioRegenerative Sciences、Immune Therapy Holdings、Evomic Science、Codiak BioSciences、Exovita biosciences、Lonza、Therapeutic Solutions International、Norgen Biotek、ReNeuron Group ・地域別グローバル市場分析 2015年-2020年 ・診断用エキソソームバイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・診断用エキソソームバイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・診断用エキソソームバイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・診断用エキソソームバイオマーカーの南米市場（ブラジル、アルゼンチン） ・診断用エキソソームバイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：膜結合タンパク質、可溶性タンパク質、ノンコーディングRNA、その他 ・用途別分析：病院、クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Diagnostic Exosome Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Diagnostic Exosome Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Diagnostic Exosome Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Diagnostic Exosome Biomarker market has been segmented into:
Membrane-bound Proteins
Soluble Proteins
Noncoding RNA
Others

By Application, Diagnostic Exosome Biomarker has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Exosome Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Exosome Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Exosome Biomarker market.

The report offers in-depth assessment of the growth and other aspects of the Diagnostic Exosome Biomarker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Diagnostic Exosome Biomarker Market Share Analysis
Diagnostic Exosome Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Exosome Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Exosome Biomarker sales, revenue and market share for each player covered in this report.

The major players covered in Diagnostic Exosome Biomarker are:
101Bio
Bio-Techne
Cell Guidance Systems
AMS Biotechnology
ExoCyte Therapeutics
BioRegenerative Sciences
Immune Therapy Holdings
Evomic Science
Codiak BioSciences
Exovita biosciences
Lonza
Therapeutic Solutions International
Norgen Biotek
ReNeuron Group

レポート目次

---

1 Diagnostic Exosome Biomarker Market Overview
1.1 Product Overview and Scope of Diagnostic Exosome Biomarker
1.2 Classification of Diagnostic Exosome Biomarker by Type
1.2.1 Global Diagnostic Exosome Biomarker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diagnostic Exosome Biomarker Revenue Market Share by Type in 2019
1.2.3 Membrane-bound Proteins
1.2.4 Soluble Proteins
1.2.5 Noncoding RNA
1.2.6 Others
1.3 Global Diagnostic Exosome Biomarker Market by Application
1.3.1 Overview: Global Diagnostic Exosome Biomarker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Diagnostic Exosome Biomarker Market by Regions
1.4.1 Global Diagnostic Exosome Biomarker Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diagnostic Exosome Biomarker (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diagnostic Exosome Biomarker Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnostic Exosome Biomarker Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnostic Exosome Biomarker Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diagnostic Exosome Biomarker Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnostic Exosome Biomarker Status and Prospect (2015-2025)
2 Company Profiles
2.1 101Bio
2.1.1 101Bio Details
2.1.2 101Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 101Bio SWOT Analysis
2.1.4 101Bio Product and Services
2.1.5 101Bio Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bio-Techne SWOT Analysis
2.2.4 Bio-Techne Product and Services
2.2.5 Bio-Techne Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cell Guidance Systems
2.3.1 Cell Guidance Systems Details
2.3.2 Cell Guidance Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cell Guidance Systems SWOT Analysis
2.3.4 Cell Guidance Systems Product and Services
2.3.5 Cell Guidance Systems Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.4 AMS Biotechnology
2.4.1 AMS Biotechnology Details
2.4.2 AMS Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AMS Biotechnology SWOT Analysis
2.4.4 AMS Biotechnology Product and Services
2.4.5 AMS Biotechnology Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.5 ExoCyte Therapeutics
2.5.1 ExoCyte Therapeutics Details
2.5.2 ExoCyte Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ExoCyte Therapeutics SWOT Analysis
2.5.4 ExoCyte Therapeutics Product and Services
2.5.5 ExoCyte Therapeutics Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioRegenerative Sciences
2.6.1 BioRegenerative Sciences Details
2.6.2 BioRegenerative Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioRegenerative Sciences SWOT Analysis
2.6.4 BioRegenerative Sciences Product and Services
2.6.5 BioRegenerative Sciences Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.7 Immune Therapy Holdings
2.7.1 Immune Therapy Holdings Details
2.7.2 Immune Therapy Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Immune Therapy Holdings SWOT Analysis
2.7.4 Immune Therapy Holdings Product and Services
2.7.5 Immune Therapy Holdings Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.8 Evomic Science
2.8.1 Evomic Science Details
2.8.2 Evomic Science Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Evomic Science SWOT Analysis
2.8.4 Evomic Science Product and Services
2.8.5 Evomic Science Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.9 Codiak BioSciences
2.9.1 Codiak BioSciences Details
2.9.2 Codiak BioSciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Codiak BioSciences SWOT Analysis
2.9.4 Codiak BioSciences Product and Services
2.9.5 Codiak BioSciences Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.10 Exovita biosciences
2.10.1 Exovita biosciences Details
2.10.2 Exovita biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Exovita biosciences SWOT Analysis
2.10.4 Exovita biosciences Product and Services
2.10.5 Exovita biosciences Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Lonza SWOT Analysis
2.11.4 Lonza Product and Services
2.11.5 Lonza Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.12 Therapeutic Solutions International
2.12.1 Therapeutic Solutions International Details
2.12.2 Therapeutic Solutions International Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Therapeutic Solutions International SWOT Analysis
2.12.4 Therapeutic Solutions International Product and Services
2.12.5 Therapeutic Solutions International Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.13 Norgen Biotek
2.13.1 Norgen Biotek Details
2.13.2 Norgen Biotek Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Norgen Biotek SWOT Analysis
2.13.4 Norgen Biotek Product and Services
2.13.5 Norgen Biotek Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.14 ReNeuron Group
2.14.1 ReNeuron Group Details
2.14.2 ReNeuron Group Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ReNeuron Group SWOT Analysis
2.14.4 ReNeuron Group Product and Services
2.14.5 ReNeuron Group Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diagnostic Exosome Biomarker Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnostic Exosome Biomarker Players Market Share
3.2.2 Top 10 Diagnostic Exosome Biomarker Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diagnostic Exosome Biomarker Revenue and Market Share by Regions
4.2 North America Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
4.3 Europe Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
4.5 South America Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
5 North America Diagnostic Exosome Biomarker Revenue by Countries
5.1 North America Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
5.2 USA Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
5.3 Canada Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
5.4 Mexico Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
6 Europe Diagnostic Exosome Biomarker Revenue by Countries
6.1 Europe Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
6.2 Germany Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
6.3 UK Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
6.4 France Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
6.5 Russia Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
6.6 Italy Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diagnostic Exosome Biomarker Revenue by Countries
7.1 Asia-Pacific Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
7.2 China Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
7.3 Japan Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
7.4 Korea Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
7.5 India Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
8 South America Diagnostic Exosome Biomarker Revenue by Countries
8.1 South America Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
8.2 Brazil Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
8.3 Argentina Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diagnostic Exosome Biomarker by Countries
9.1 Middle East & Africa Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
9.3 UAE Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
9.4 Egypt Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
9.5 South Africa Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diagnostic Exosome Biomarker Revenue and Market Share by Type (2015-2020)
10.2 Global Diagnostic Exosome Biomarker Market Forecast by Type (2019-2024)
10.3 Membrane-bound Proteins Revenue Growth Rate (2015-2025)
10.4 Soluble Proteins Revenue Growth Rate (2015-2025)
10.5 Noncoding RNA Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Diagnostic Exosome Biomarker Market Segment by Application
11.1 Global Diagnostic Exosome Biomarker Revenue Market Share by Application (2015-2020)
11.2 Diagnostic Exosome Biomarker Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Diagnostic Exosome Biomarker Market Size Forecast (2021-2025)
12.1 Global Diagnostic Exosome Biomarker Market Size Forecast (2021-2025)
12.2 Global Diagnostic Exosome Biomarker Market Forecast by Regions (2021-2025)
12.3 North America Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
12.4 Europe Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
12.6 South America Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Diagnostic Exosome Biomarker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnostic Exosome Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnostic Exosome Biomarker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diagnostic Exosome Biomarker Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. 101Bio Corporate Information, Location and Competitors
Table 6. 101Bio Diagnostic Exosome Biomarker Major Business
Table 7. 101Bio Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 8. 101Bio SWOT Analysis
Table 9. 101Bio Diagnostic Exosome Biomarker Product and Solutions
Table 10. 101Bio Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bio-Techne Corporate Information, Location and Competitors
Table 12. Bio-Techne Diagnostic Exosome Biomarker Major Business
Table 13. Bio-Techne Diagnostic Exosome Biomarker Total Revenue (USD Million) (2018-2019)
Table 14. Bio-Techne SWOT Analysis
Table 15. Bio-Techne Diagnostic Exosome Biomarker Product and Solutions
Table 16. Bio-Techne Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cell Guidance Systems Corporate Information, Location and Competitors
Table 18. Cell Guidance Systems Diagnostic Exosome Biomarker Major Business
Table 19. Cell Guidance Systems Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 20. Cell Guidance Systems SWOT Analysis
Table 21. Cell Guidance Systems Diagnostic Exosome Biomarker Product and Solutions
Table 22. Cell Guidance Systems Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AMS Biotechnology Corporate Information, Location and Competitors
Table 24. AMS Biotechnology Diagnostic Exosome Biomarker Major Business
Table 25. AMS Biotechnology Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 26. AMS Biotechnology SWOT Analysis
Table 27. AMS Biotechnology Diagnostic Exosome Biomarker Product and Solutions
Table 28. AMS Biotechnology Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. ExoCyte Therapeutics Corporate Information, Location and Competitors
Table 30. ExoCyte Therapeutics Diagnostic Exosome Biomarker Major Business
Table 31. ExoCyte Therapeutics Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 32. ExoCyte Therapeutics SWOT Analysis
Table 33. ExoCyte Therapeutics Diagnostic Exosome Biomarker Product and Solutions
Table 34. ExoCyte Therapeutics Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BioRegenerative Sciences Corporate Information, Location and Competitors
Table 36. BioRegenerative Sciences Diagnostic Exosome Biomarker Major Business
Table 37. BioRegenerative Sciences Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 38. BioRegenerative Sciences SWOT Analysis
Table 39. BioRegenerative Sciences Diagnostic Exosome Biomarker Product and Solutions
Table 40. BioRegenerative Sciences Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Immune Therapy Holdings Corporate Information, Location and Competitors
Table 42. Immune Therapy Holdings Diagnostic Exosome Biomarker Major Business
Table 43. Immune Therapy Holdings Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 44. Immune Therapy Holdings SWOT Analysis
Table 45. Immune Therapy Holdings Diagnostic Exosome Biomarker Product and Solutions
Table 46. Immune Therapy Holdings Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Evomic Science Corporate Information, Location and Competitors
Table 48. Evomic Science Diagnostic Exosome Biomarker Major Business
Table 49. Evomic Science Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 50. Evomic Science SWOT Analysis
Table 51. Evomic Science Diagnostic Exosome Biomarker Product and Solutions
Table 52. Evomic Science Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Codiak BioSciences Corporate Information, Location and Competitors
Table 54. Codiak BioSciences Diagnostic Exosome Biomarker Major Business
Table 55. Codiak BioSciences Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 56. Codiak BioSciences SWOT Analysis
Table 57. Codiak BioSciences Diagnostic Exosome Biomarker Product and Solutions
Table 58. Codiak BioSciences Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Exovita biosciences Corporate Information, Location and Competitors
Table 60. Exovita biosciences Diagnostic Exosome Biomarker Major Business
Table 61. Exovita biosciences Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 62. Exovita biosciences SWOT Analysis
Table 63. Exovita biosciences Diagnostic Exosome Biomarker Product and Solutions
Table 64. Exovita biosciences Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Lonza Corporate Information, Location and Competitors
Table 66. Lonza Diagnostic Exosome Biomarker Major Business
Table 67. Lonza Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 68. Lonza SWOT Analysis
Table 69. Lonza Diagnostic Exosome Biomarker Product and Solutions
Table 70. Lonza Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Therapeutic Solutions International Corporate Information, Location and Competitors
Table 72. Therapeutic Solutions International Diagnostic Exosome Biomarker Major Business
Table 73. Therapeutic Solutions International Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 74. Therapeutic Solutions International SWOT Analysis
Table 75. Therapeutic Solutions International Diagnostic Exosome Biomarker Product and Solutions
Table 76. Therapeutic Solutions International Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Norgen Biotek Corporate Information, Location and Competitors
Table 78. Norgen Biotek Diagnostic Exosome Biomarker Major Business
Table 79. Norgen Biotek Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 80. Norgen Biotek SWOT Analysis
Table 81. Norgen Biotek Diagnostic Exosome Biomarker Product and Solutions
Table 82. Norgen Biotek Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. ReNeuron Group Corporate Information, Location and Competitors
Table 84. ReNeuron Group Diagnostic Exosome Biomarker Major Business
Table 85. ReNeuron Group Diagnostic Exosome Biomarker Total Revenue (USD Million) (2017-2018)
Table 86. ReNeuron Group SWOT Analysis
Table 87. ReNeuron Group Diagnostic Exosome Biomarker Product and Solutions
Table 88. ReNeuron Group Diagnostic Exosome Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Diagnostic Exosome Biomarker Revenue (Million USD) by Players (2015-2020)
Table 90. Global Diagnostic Exosome Biomarker Revenue Share by Players (2015-2020)
Table 91. Global Diagnostic Exosome Biomarker Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Diagnostic Exosome Biomarker Revenue Market Share by Regions (2015-2020)
Table 93. North America Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
Table 94. North America Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Table 95. Europe Diagnostic Exosome Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Diagnostic Exosome Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Diagnostic Exosome Biomarker Revenue by Countries (2015-2020)
Table 98. South America Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Diagnostic Exosome Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Table 101. Global Diagnostic Exosome Biomarker Revenue (Million USD) by Type (2015-2020)
Table 102. Global Diagnostic Exosome Biomarker Revenue Share by Type (2015-2020)
Table 103. Global Diagnostic Exosome Biomarker Revenue Forecast by Type (2021-2025)
Table 104. Global Diagnostic Exosome Biomarker Revenue by Application (2015-2020)
Table 105. Global Diagnostic Exosome Biomarker Revenue Share by Application (2015-2020)
Table 106. Global Diagnostic Exosome Biomarker Revenue Forecast by Application (2021-2025)
Table 107. Global Diagnostic Exosome Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diagnostic Exosome Biomarker Picture
Figure 2. Global Diagnostic Exosome Biomarker Revenue Market Share by Type in 2019
Figure 3. Membrane-bound Proteins Picture
Figure 4. Soluble Proteins Picture
Figure 5. Noncoding RNA Picture
Figure 6. Others Picture
Figure 7. Diagnostic Exosome Biomarker Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Ambulatory Surgical Centers Picture
Figure 11. Global Diagnostic Exosome Biomarker Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Diagnostic Exosome Biomarker Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Diagnostic Exosome Biomarker Revenue Market Share in 2019
Figure 20. Global Top 10 Players Diagnostic Exosome Biomarker Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Diagnostic Exosome Biomarker Revenue Market Share by Regions (2015-2020)
Figure 24. Global Diagnostic Exosome Biomarker Revenue Market Share by Regions in 2018
Figure 25. North America Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 26. Europe Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 28. South America Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 30. North America Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Figure 31. North America Diagnostic Exosome Biomarker Revenue Market Share by Countries in 2019
Figure 32. USA Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 33. Canada Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 35. Europe Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Diagnostic Exosome Biomarker Revenue Market Share by Countries in 2019
Figure 37. Germany Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 38. UK Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 39. France Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 40. Russia Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 41. Italy Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Diagnostic Exosome Biomarker Revenue Market Share by Countries in 2019
Figure 44. China Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 45. Japan Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 46. Korea Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 47. India Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 49. South America Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Figure 50. South America Diagnostic Exosome Biomarker Revenue Market Share by Countries in 2019
Figure 51. Brazil Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Diagnostic Exosome Biomarker Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Diagnostic Exosome Biomarker Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 56. UAE Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Diagnostic Exosome Biomarker Revenue and Growth Rate (2015-2020)
Figure 59. Global Diagnostic Exosome Biomarker Revenue Share by Type (2015-2020)
Figure 60. Global Diagnostic Exosome Biomarker Revenue Share by Type in 2019
Figure 61. Global Diagnostic Exosome Biomarker Market Share Forecast by Type (2021-2025)
Figure 62. Global Membrane-bound Proteins Revenue Growth Rate (2015-2020)
Figure 63. Global Soluble Proteins Revenue Growth Rate (2015-2020)
Figure 64. Global Noncoding RNA Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Diagnostic Exosome Biomarker Revenue Share by Application (2015-2020)
Figure 67. Global Diagnostic Exosome Biomarker Revenue Share by Application in 2019
Figure 68. Global Diagnostic Exosome Biomarker Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Diagnostic Exosome Biomarker Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Diagnostic Exosome Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Diagnostic Exosome Biomarker Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
Figure 76. Europe Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
Figure 78. South America Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Diagnostic Exosome Biomarker Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---